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Abstract 
Purpose:  The observation periods and thresholds on serum creatinine and urine output defined 
in the Acute Kidney Injury Network (AKIN) criteria were not empirically derived. By 
continuously varying creatinine/urine output thresholds as well as observation period, we sought 
to investigate the empirical relationships among creatinine, oliguria, in-hospital mortality, and 
receipt of renal replacement therapy (RRT). 
Methods: Using a high-resolution database (MIMIC-II), we extracted data from 17,227 critically 
ill patients with an in-hospital mortality rate of 10.9%. 14,526 patients had urine output 
measurements. Various combinations of creatinine/urine output thresholds and observation 
periods were investigated by building multivariate logistic regression models for in-hospital 
mortality and RRT predictions. For creatinine, both absolute and percentage increases were 
analyzed. To visualize the dependence of adjusted mortality and RRT rate on creatinine, urine 
output, and observation period, we generated contour plots. 
Results: Mortality risk was high when absolute creatinine increase was high regardless of 
observation period, when percentage creatinine increase was high and observation period was 
long, and when oliguria was sustained for a long period of time. Similar contour patterns 
emerged for RRT. The variability in predictive accuracy was small across different combinations 
of thresholds and observation periods. 
Conclusions: The contour plots presented in this article complement the AKIN definition. A 
multi-center study should confirm the universal validity of the results presented in this article. 
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Introduction 
 
Between 5% and 7% [1] of all hospitalized patients develop acute kidney injury (AKI) during 
their hospital stay, increasing to between 26% and 49% in the critically ill [2-5]. However, AKI 
has not been consistently defined, with over 30 different definitions appearing in the literature 
[6]. In 2004, the Acute Dialysis Quality Initiative (ADQI) published the first widely accepted 
definition of AKI, the RIFLE criteria [7, 8]. Subsequently, a number of studies, largely in 
vascular and cardiothoracic patients, demonstrated that even small absolute increases in serum 
creatinine can indicate AKI and are correlated with increased mortality [9, 10]. In 2005, the 
Acute Kidney Injury Network (AKIN) proposed a revision to the RIFLE criteria on creatinine. 
The urine output criteria had originally been established by RIFLE and were confirmed by 
AKIN. The AKIN criteria were first published by Mehta et al. in 2007 [7]. For a rigorous 
comparison between RIFLE and AKIN, please see the study conducted by Joannidis et al. [11]. 
In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) published the most recent 
clinical guideline for AKI [12], which summarizes the AKIN and RIFLE criteria.  
The AKIN criteria are based on both serum creatinine and urine output (Table E1 in the 
Electronic Supplemental Material), because creatinine and urine output may not always agree 
with each other. Recently, Prowle and colleagues demonstrated that transient oliguria was a 
common event in the intensive care unit (ICU) and that such incidents were not necessarily 
associated with development of AKI by creatinine criteria [13]. The AKIN threshold of 0.3mg/dl 
for absolute increase in creatinine was taken from a study by Chertow et al. [1] which used a 
large cohort of hospitalized patients. In that study, Chertow and colleagues demonstrated a 4-fold 
adjusted increase in mortality risk even with this minimal increase in serum creatinine. This 
finding was confirmed in two subsequent large retrospective cohort studies [14, 15]. Hourly 
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urine output measurements are part of both the RIFLE and AKIN classifications, primarily 
because changes in urine output often precede the corresponding rise in serum creatinine [16]. 
The minimum hourly urine output rate currently in use to define oliguria (less than 0.5 ml/kg/h) 
was based on clinical experience and animal models, not on clinical investigation. Moreover, the 
minimum duration of oliguria currently being used by the AKIN criteria (6 hours) was proposed 
by clinicians at the Amsterdam consensus conference and was not experimentally determined. 
Hence, despite that the creatinine threshold of 0.3 mg/dl was based on a formal investigation and 
that severity of illness scoring systems (e.g., SAPS, APACHE, etc.) provided a general 
framework, the AKIN criteria were largely derived by consensus. 
Using an intensive care database with high resolution measurements of creatinine and urine 
output (namely, MIMIC-II [17]), we have previously analyzed the relationship between the three 
AKIN stages and mortality [18]. The high-resolution feature of MIMIC-II facilitates a complete 
empirical AKI study. Therefore, in the present study, we sought to empirically examine the 
relationships among serum creatinine, urine output, mortality, and renal replacement therapy, in 
a large cohort of critically ill patients. The relationships were investigated by continuously 
varying observation period and thresholds on creatinine increase and urine output. The primary 
objective of the present study was to provide useful clinical information that complements the 
AKIN criteria, which implement only a few thresholds and observation periods. 
Methods 
Data Source and Patient Cohort 
The Multiparameter Intelligent Monitoring in Intensive Care II (MIMIC-II) database (version 
2.5) [17] is a National Institutes of Health funded, publicly available database of high-resolution, 
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de-identified clinical data developed at Massachusetts Institute of Technology (MIT) and Beth 
Israel Deaconess Medical Center (BIDMC). Data were collected from more than 25,000 ICU 
patients at BIDMC, an urban, tertiary care university hospital located in Boston, Massachusetts, 
USA. In particular, MIMIC-II contains high resolution urine output measurements and serum 
creatinine lab test results from a diverse sample of critically ill patients, making it ideally suited 
for the present study.  
We included data from the first ICU stay of all adult (15 years or older) patients who were 
admitted to BIDMC’s ICUs between 2001 and 2007. We excluded patients who had a total 
length of stay less than 24 hours, less than two serum creatinine measurements, or end stage 
renal disease (ESRD) on admission (identified based on ICD9, admission creatinine > 4 mg/dl, 
and text search; please see [18] for details). In addition, we excluded patients weighing more 
than 130 kg due to suspected data entry errors.  
The MIMIC-II project was approved by the Institutional Review Boards of MIT and BIDMC, 
and granted a waiver of informed consent [17]. Oracle (Redwood Shores, CA, USA) SQL 
Developer version 3.1.07 was used for data extraction. 
Study Variables and Outcomes 
The primary predictor variable was a binary AKI indicator based on a given choice of a 
measurement threshold and an observation period.  This binary predictor was given a value of 1 
if the patient had at least one time window that met the threshold and observation period under 
investigation. The measurement thresholds were varied from 0.1 to 1.0 mg/dl with a 0.1 
increment, from 125 to 400 % with a 25%-point increment, and from 0.1 to 1.0 ml/kg/h with a 
0.1 increment for absolute creatinine increase, percentage creatinine increase, and urine output, 
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respectively. The observation periods were varied from 1 to 7 days with a 1 day increment for 
both absolute and percentage creatinine increases, and from 2 to 48 hours with a 1 hour 
increment for urine output. In MIMIC-II, serum creatinine and urine output are usually recorded 
daily and hourly, respectively. For increases in creatinine, the maximum increase between two 
creatinine measurements separated by less than a given observation period was considered. For 
urine output, the sum of all urine output measurements within an observation period was divided 
by the duration of the observation period and the patient’s weight. 
ICU nurses at BIDMC sometimes recorded urine output measurements for a period longer than 
one hour. To ensure adequate quality on urine output data, valid windows were required to have 
a measurement available for at least 50% of the number of hours in the window and have a 
maximum gap of two hours between subsequent measurements. We excluded windows which 
did not meet the above criteria.  
The primary outcome variable was in-hospital mortality. As a secondary outcome, we also 
analyzed the receipt of renal replacement therapy (RRT) during the hospital admission (for acute 
and other reasons, but not due to ESRD), which was identified using Current Procedural 
Terminology (CPT) codes. Whereas mortality represents general severity of illness, RRT may be 
a more relevant end point from an AKI management standpoint. 
The following confounding variables were included: age, gender, administration of vasoactive 
medications, mechanical ventilation, primary diagnosis by Diagnosis Related Group (DRG), 
service type (medical or surgical), Sequential Organ Failure Assessment (SOFA) [19] scores 
from the first ICU day, and Elixhauser comorbidities [20].  
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Statistical Analyses 
A separate multivariate logistic regression model was built for each combination of 
creatinine/urine output threshold and observation period. A total of three analyses were 
conducted: absolute creatinine increase, percentage creatinine increase, and urine output. Since 
each analysis varied two parameters (threshold for creatinine increase or urine output, and 
observation period), formation of all possible threshold combinations resulted in the generation 
of multiple regression models: 70, 84, and 470 models for the absolute creatinine increase, 
percentage creatinine increase, and urine output analyses, respectively. 
Two values were obtained from each regression model for analysis: adjusted mortality or RRT 
rate, and predictive accuracy. For each combination of threshold and observation period, the 
adjusted mortality or RRT rate was computed to be the median of the output values of the 
corresponding logistic regression model among the patients who were deemed to have AKI 
according to the chosen threshold and observation period. The adjusted mortality and RRT rates 
took into account the confounders, hence making it possible to compare different sets of 
thresholds. The mortality or RRT predictive power was quantified by computing the area under 
the receiver operating characteristic curve (AUC) of the corresponding regression model using 
10-fold cross-validation [21].  
We generated contour plots to visualize the dependence of adjusted mortality/RRT rate and AUC 
on creatinine, urine output, and observation period. In each plot, the independent variables were 
creatinine or urine output threshold and observation period, whereas the dependent variable was 
either adjusted mortality or RRT rate or AUC. The contour plots employed two-dimensional 
cubic spline interpolation on the fine-grids generated by the regression models. Furthermore, in 
order to examine the AKIN criteria, the cross-sections of the adjusted mortality or RRT contour 
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plots at the AKIN observation periods (2 days for creatinine and 6, 12, and 24 hours for urine 
output) were plotted separately. 
All analyses were conducted using MATLAB (Natick, MA, USA) version R2010b. 
Results 
The MIMIC-II database (version 2.5) contains the records of 26,576 patients of whom 19,742 
were aged 15 years or older at the time of admission and included in the study. 1,305 patients 
(6.6%) who had ESRD prior to their ICU admission were excluded. An additional 1,210 patients 
(6.1%) were excluded due to insufficient creatinine measurements, length of stay less than 24 
hours, or missing data for the generation of the logistic regression models. The final analytic 
cohort used for the creatinine analyses (absolute and percentage) consisted of 17,227 patients. Of 
these, 14,526 had sufficient data for the urine output analysis. For a detailed description of the 
cohort, please see the Electronic Supplemental Material. 
Figure 1(A) is the contour plot showing adjusted in-hospital mortality as a function of absolute 
creatinine increase and observation period. Regardless of observation period, mortality risk 
increased with greater absolute creatinine increases but especially rapidly when the observation 
period was less than two days. However, for observation periods longer than two days, mortality 
risk was independent of observation period.  
Figure 1(B) illustrates adjusted in-hospital mortality as a function of percentage creatinine 
increase and observation period. When creatinine increases were below 200%, in-hospital 
mortality was independent of observation period. For creatinine increases greater than 200%, 
mortality risk increased with longer observation periods and larger percentage creatinine 
increases. The decrease in mortality when observation period was short and percentage increase 
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was large (i.e., the bottom right corner of the contour plot) is likely an artifact due to a very small 
number patients meeting the AKI criteria (<100). 
Figure 1(C) describes adjusted in-hospital mortality as a function of urine output and observation 
period. When urine output was less than 0.5 ml/kg/h, mortality rate increased rapidly as urine 
output decreased. However, when urine output was greater than 0.5 ml/kg/h, there was a minimal 
reduction in mortality rate as urine output increased. Furthermore, for urine outputs less than 0.3 
ml/kg/h and observation periods shorter than 5 hours, mortality risk was especially sensitive to 
the degree of oliguria and longer observation time. Mortality risk became independent of the 
duration of oliguria for observation periods longer than approximately 24 hours (i.e., the upper 
half of the contour plot). 
The three contour plots in Figure 2 depict adjusted RRT rate as a function of creatinine increase 
or urine output, and observation period. The patterns in Figure 2 are similar to those in Figure 1, 
suggesting that in-hospital mortality and receipt of RRT were closely related. 
Please see the Electronic Supplemental Material for the cross-sections of Figure 1 and 2 at the 
AKIN criteria, as well as for the AUC contour plots for in-hospital mortality and RRT 
predictions. 
Discussion 
Using a large cohort of unselected critically ill patients, we aimed to investigate the empirical 
relationships among serum creatinine, urine output, observation period, in-hospital mortality, and 
RRT. The primary contribution of the present study is the contour plots shown in Figure 1 and 2. 
Whereas the criteria for the three AKIN stages (Table E1) are simply points on the contour plots 
(except some of the AKI 3 criteria such as need for RRT), Figure 1 and 2 provide physicians 
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with more complete pictures of AKI with respect to in-hospital mortality risk and anticipated 
need for RRT. In general, the severity of AKI was high when 1) absolute creatinine increase was 
high regardless of observation period, 2) percentage creatinine increase was high and observation 
period was long, and 3) oliguria was sustained for a long period of time. Similar contour patterns 
emerged for both in-hospital mortality and RRT rates. In addition, Figure E1 and E2 present 
further insight into the AKIN criteria by focusing on the observation periods specified by AKIN.  
One can argue that clinicians can utilize Figure 1 and 2 as nomograms for their own patients. 
Improved risk prediction may lead to improved AKI management in terms of medication 
adjustment and early initiation of appropriate preventative procedures. However, one major 
concern in this regard is the fact that Figure 1 and 2 were generated from a single-center 
database, which may limit the universal validity of the contour plots. Since it is unlikely that 
high-resolution urine output and creatinine measurements would be available in any multi-center 
database, a logical step is to generate knowledge from an appropriate database such as MIMIC-II 
and validate the results in a multi-center data set. Hence, we strongly advocate a multi-center 
study to follow the present study. 
Furthermore, the present study simplified the AKI investigation by analyzing only one of the 
three variables (absolute and percentage creatinine increases, and urine output) at a time. It 
would be of great interest and importance to investigate the synergistic predictive performance 
arising from a combination of two or more variables. Such a joint analysis is worthy of future 
research. 
The AUCs of all regression models were above the generally accepted value of 0.7 (see the 
Electronic Supplemental Material). Although the variability in AUC was small in Figure E3 and 
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E4, the combinations of threshold and observation period associated with the highest AUCs can 
be useful in maximizing predictive accuracy. It is worthwhile to note that urine output slightly 
outperformed creatinine in mortality prediction (Figure E3), which corroborates our findings in a 
previous study [18]. From a clinical standpoint, urine output features several advantages over 
creatinine such as an earlier indication of deterioration in renal function and no need for blood 
draws. On the other hand, in RRT prediction, absolute increase in creatinine resulted in the 
highest median AUC (Figure E4). 
This study has a number of limitations. First, the database contains data from a period of 7 years 
(2001-2007), during which there were changes in management of the critically ill (e.g. early goal 
directed therapy) and therefore possibly in patients outcome. Because the MIMIC II database is 
completely de-identified, we were unable to segment patients temporally. Second, we excluded 
patients with insufficient measurement data. The missing data were most likely data entry errors 
and not a result of deliberate clinical judgment. We treated them analytically as randomly 
distributed within the population. Third, we used AUC as a measure of predictive performance. 
While AUC is a good measure of discrimination, it assumes equal weights for sensitivity and 
specificity. In different clinical contexts, sensitivity may be more important than specificity and 
vice-versa. Fourth, because MIMIC-II contains urine output data only from ICU stays, we were 
unable to capture any AKI episodes that may have occurred prior to ICU admission. Finally, 
although our study included data from more than 17,000 patients and had strong statistical 
power, it was still a retrospective analysis with its characteristic limitations.  
Conclusions 
Using a large high-resolution ICU database, we generated empirical relationships among serum 
creatinine increase, urine output, observation period, in-hospital mortality, and need for RRT. 
12 
	  
The results of the present study complement the AKIN criteria. A multi-center study should 
confirm the external validity of the results presented in this article. 
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Figure Captions 
 
Figure 1 – Adjusted in-hospital mortality rate contour plots for (A) absolute increase in serum 
creatinine (N=17,227), (B) percentage increase in serum creatinine (N=17,227), and (C) urine 
output (N=14,526). Adjusted mortalities were evaluated at a fine grid of observation periods and 
thresholds (steps of 1 day, 1 hour, 0.1 mg/dl, 25% points, and 0.1ml/kg/h), and the contour plots 
were produced using cubic spline interpolation. 
 
Figure 2 – Adjusted renal replacement therapy rate contour plots for (A) absolute increase in 
serum creatinine (N=17,227), (B) percentage increase in serum creatinine (N=17,227), and (C) 
urine output (N=14,526). Adjusted mortalities were evaluated at a fine grid of observation 
periods and thresholds (steps of 1 day, 1 hour, 0.1 mg/dl, 25% points, and 0.1ml/kg/h), and the 
contour plots were produced using cubic spline interpolation. 
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Electronic Supplemental Material 
 
1. AKIN Criteria 
 
Table E1 - Classification of acute kidney injury proposed by AKIN [7] 
Stage Serum creatinine criteria (over 48-hour period) Urine output criteria 
1 ↑ Serum creatinine ≥ 0.3 mg/dl (≥ 26.4 µmol/l)  
or ↑ 150-200 % (1.5- to 2-fold) from baseline 
< 0.5 ml/kg/h for more than 6 h 
2 ↑ Serum creatinine 200-300 % (> 2- to 3-fold) from 
baseline 
< 0.5 ml/kg/h for more than 12 h 
3 ↑ Serum creatinine > 300 % (> 3-fold) from baseline 
or serum creatinine ≥ 4 mg/dl (≥ 354 µmol/l) with an 
acute increase of at least 0.5 mg/dl (44 µmol/l) 
or need for renal replacement therapy 
< 0.3 ml/kg/h for more than 24 h 
or anuria for 12 h 
 
2. Final Analytic Cohort 
The final analytic cohort used for the creatinine analyses (absolute and percentage) consisted of 
17,227 patients. Of these, 14,526 had sufficient data for the urine output analysis. 9,080 patients 
fulfilled the AKIN criteria at least once during their ICU stay. The cohort consisted of 7,453 
women (43.3%). The median age on admission was 65.3 years (interquartile range (IQR): 51.3, 
77.7). The median SOFA score on admission was 5 (IQR: 2, 8). Other demographic data are 
presented in Table E2. 
Table E2- Patient characteristics, stratified by in-hospital mortality 
 Survivors Expired Total 
Number of patients: N (%) 15,353(89.1) 1,874 (10.9) 17,227 (100) 
Female: N (%) 6,536 (42.6) 917 (48.9) 7,453 (43.3) 
Age, years: median (IQR) 64.2 (50.4, 76.8) 74.6 (60.4, 83) 65.3 (51.3, 77.7) 
SOFA: median (IQR) 5 (2,8) 8(5,11) 5 (2, 8) 
2 
 
Vasoactive therapy: N (%) 5,177 (33.7) 1,103 (58.9) 6,280 (36.5) 
Mechanical ventilation: N (%) 7,856 (51.2) 1,419 (75.7) 9,275 (53.8) 
Renal replacement therapy: N (%) 157 (1.0) 136 (7.3) 293 (1.7) 
Medical service: N (%) 7,667 (49.9) 1,177 (62.8) 8,844 (51.3) 
Selected Elixhauser comorbidities: N (%)    
     Congestive heart failure 2,476 (16.1) 532 (28.4) 3,008 (17.5) 
     Cardiac arrhythmias 2,398 (15.6) 490 (26.1) 2,888 (16.8) 
     Hypertension 4,824 (31.4) 550 (29.3) 5,374 (31.2) 
     Chronic pulmonary disease 2,411 (15.7) 318 (17.0) 2,729 (15.8) 
     Diabetes 3,399 (22.1) 355 (18.9) 3,754 (21.8) 
     Renal failure 460 (3.0) 101 (5.4) 561 (3.3) 
     Liver disease 603 (3.9) 124 (6.6) 727 (4.2) 
     Lymphoma 212 (1.4) 59 (3.1) 271 (1.6) 
     Coagulopathy 796 (5.2) 161 (8.6) 957 (5.6) 
 
A total of 417 patients were excluded from this study due to missing data. The median age and 
SOFA score of these excluded patients were 62.2 years (IQR: 47.3, 76.2) and 5 (IQR: 2, 9), 
respectively. Also, 41.2% were women and 68.1% were medical patients. In-hospital mortality 
and RRT rates were 9.4% and 2.2%, respectively. Besides the higher percentage of medical 
patients, the excluded patients were similar to the included patients with respect to descriptive 
statistics. 
 
3. Cross-sections of Figures 1 and 2 at the AKIN Criteria 
Figures E1 and E2 draw parallels to the AKIN criteria by showing the cross-sections of Figs. 1 
and 2, respectively, at the observation periods utilized by AKIN. Figures E1(A) and E2(A) show 
a near-linear relationship between mortality/RRT rate and absolute creatinine increase. Figures 
E1(B) and E2(B) also show an approximately linear relationship between mortality/RRT and 
percentage creatinine increase up to a creatinine increase of 300%. In Fig. E1(B), creatinine 
increases above 350% actually resulted in decreased mortality rates, which may again be due to a 
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small number of deemed AKI patients (<100). As seen in Figs. E1(C) and E2(C), mortality and 
RRT rates increased rapidly as urine output decreased below 0.4 ml/kg/h. Also, longer 
observation periods were associated with higher mortality and RRT rates. 
 
Figure E1 – Cross-sections of Fig. 1 at the AKIN observation periods illustrating the 
relationship between adjusted in-hospital mortality rate and (A) absolute increase in serum 
creatinine at 2 days (N=17,227), (B) percentage increase in serum creatinine at 2 days 
(N=17,227), and (C) urine output at 6, 12, 24 hours (N=14,526).  
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Figure E2 – Cross-sections of Fig. 2 at the AKIN observation periods illustrating the 
relationship between adjusted renal replacement therapy rate and (A) absolute increase in 
serum creatinine at 2 days (N=17,227), (B) percentage increase in serum creatinine at 2 
days (N=17,227), and (C) urine output at 6, 12, 24 hours (N=14,526). 
 
 
 
5 
 
4. AUC Contour Plots for In-hospital Mortality and RRT Predictions 
Figures E3 and E4 show AUC contour plots for in-hospital mortality and RRT predictions, 
respectively. In both figures, some specific combinations of threshold and observation period are 
associated with the highest AUCs (e.g., 170 % and 6 days in Fig. E3(B)). However, the 
variability in AUC is small in each plot (the following shown in median (IQR)): Fig. E3(A) – 
0.790 (0.788, 0.791); Fig. E3(B) – 0.784 (0.782, 0.786); Fig. E3(C) – 0.806 (0.801, 0.809); Fig. 
E4(A) – 0.932 (0.922, 0.935); Fig. E4(B) – 0.908 (0.901, 0.915); Fig. E4(C) – 0.904 (0.896, 
0.914). 
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Figure E3 – In-hospital mortality prediction AUC contour plots for (A) absolute increase in 
serum creatinine (N=17,227), (B) percentage increase in serum creatinine (N=17,227), and 
(C) urine output (N=14,526). The predictive performance of the corresponding regression 
models in Fig. 1 is shown. AUCs were evaluated at a fine grid of observation periods and 
thresholds (steps of 1 day, 1 h, 0.1 mg/dl, 25 %-points, and 0.1 ml/kg/h), and the contour 
plots were produced using cubic spline interpolation. 
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Figure E4 - Renal replacement therapy prediction AUC contour plots for (A) absolute 
increase in serum creatinine (N=17,227), (B) percentage increase in serum creatinine 
(N=17,227), and (C) urine output (N=14,526). The predictive performance of the 
corresponding regression models in Fig. 2 is shown. AUCs were evaluated at a fine grid of 
observation periods and thresholds (steps of 1 day, 1 h, 0.1 mg/dl, 25 %-points, and 0.1 
ml/kg/h), and the contour plots were produced using cubic spline interpolation. 
 
 
Absolute creatinine increase threshold (mg/dl)
O
bs
er
va
tio
n 
pe
rio
d 
(da
ys
)
 
 
Ad
jus
ted
 m
ort
ali
ty 
rat
e (
%)
(A)
0.2 0.4 0.6 0.8 1
1
2
3
4
5
6
7
15
20
25
30
35
40
Percentage creatinine increase threshold (%)
O
bs
er
va
tio
n 
pe
rio
d 
(da
ys
)
 
 
Ad
jus
ted
 m
ort
ali
ty 
rat
e (
%)
(B)
150 200 250 300 350 400
1
2
3
4
5
6
7
15
20
25
30
35
40
Urine output threshold (ml/kg/h)
O
bs
er
va
tio
n 
pe
rio
d 
(h)
 
 
Ad
jus
ted
 m
ort
ali
ty 
rat
e (
%)
(C)
0.2 0.4 0.6 0.8 1
10
20
30
40
20
30
40
50
60
70
Absolute creatinine increase threshold (mg/dl)
O
bs
er
va
tio
n 
pe
rio
d 
(da
ys
)
 
 
Ad
jus
ted
 R
RT
 ra
te 
(%
)
(A)
0.2 0.4 0.6 0.8 1
1
2
3
4
5
6
7
5
10
15
20
Percentage creatinine increase threshold (%)
O
bs
er
va
tio
n 
pe
rio
d 
(da
ys
)
 
 
Ad
jus
ted
 R
RT
 ra
te 
(%
)
(B)
150 200 250 300 350 400
1
2
3
4
5
6
7
5
10
15
20
Urine output threshold (ml/kg/h)
O
bs
er
va
tio
n 
pe
rio
d 
(h)
 
 
Ad
jus
ted
 R
RT
 ra
te 
(%
)
(C)
0.2 0.4 0.6 0.8 1
10
20
30
40
10
20
30
40
50
60
